Citigroup’s Tenaya Therapeutics TNYA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $22.4K | Sell |
36,679
-2,095
| -5% | -$1.28K | ﹤0.01% | 4317 |
|
|
2025
Q1 | $22.1K | Sell |
38,774
-4,733
| -11% | -$2.7K | ﹤0.01% | 4302 |
|
|
2024
Q4 | $62.2K | Buy |
43,507
+3,400
| +8% | +$4.86K | ﹤0.01% | 4179 |
|
|
2024
Q3 | $77.4K | Buy |
40,107
+27,793
| +226% | +$53.6K | ﹤0.01% | 4103 |
|
|
2024
Q2 | $38.2K | Sell |
12,314
-1,795
| -13% | -$5.57K | ﹤0.01% | 3999 |
|
|
2024
Q1 | $73.8K | Buy |
14,109
+7,307
| +107% | +$38.2K | ﹤0.01% | 3694 |
|
|
2023
Q4 | $22K | Buy |
6,802
+6,320
| +1,311% | +$20.5K | ﹤0.01% | 4205 |
|
|
2023
Q3 | $1.23K | Sell |
482
-13,608
| -97% | -$34.7K | ﹤0.01% | 4302 |
|
|
2023
Q2 | $82.7K | Buy |
14,090
+13,651
| +3,110% | +$80.1K | ﹤0.01% | 3665 |
|
|
2023
Q1 | $1.25K | Sell |
439
-250
| -36% | -$712 | ﹤0.01% | 4416 |
|
|
2022
Q4 | $1.39K | Sell |
689
-160,837
| -100% | -$323K | ﹤0.01% | 4570 |
|
|
2022
Q3 | $468K | Buy |
161,526
+158,807
| +5,841% | +$460K | ﹤0.01% | 2630 |
|
|
2022
Q2 | $15K | Buy |
2,719
+716
| +36% | +$3.95K | ﹤0.01% | 4453 |
|
|
2022
Q1 | $24K | Sell |
2,003
-2,818
| -58% | -$33.8K | ﹤0.01% | 4330 |
|
|
2021
Q4 | $91K | Buy |
4,821
+3,232
| +203% | +$61K | ﹤0.01% | 4020 |
|
|
2021
Q3 | $33K | Buy |
+1,589
| New | +$33K | ﹤0.01% | 4235 |
|